Detection of Mycobacterium kansasii infection in a rhesus macaque (Macaca mulatta) using a modified QuantiFERON-TB Gold assay

被引:11
作者
Parsons, Sven D. C. [1 ]
de Villiers, Charon [2 ]
Gey van Pittius, Nicolaas C. [1 ]
Warren, Robin M. [1 ]
van Helden, Paul D. [1 ]
机构
[1] Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci,Div Mol Biol & Human Genet, DST,NRF Ctr Excellence Biomed TB Res,MRC Ctr Mol, ZA-7505 Tygerberg, South Africa
[2] S Africa Delft Anim Ctr, MRC, ZA-7505 Tygerberg, South Africa
关键词
Diagnosis; Interferon-gamma; Mycobacterium kansasii; Mycobacterium tuberculosis; Rhesus macaque; Tuberculosis; NONHUMAN-PRIMATES; TUBERCULOSIS INFECTION; DIAGNOSIS; GAMMA; INTERFERON; BOVIS; RESPONSES; IDENTIFICATION; PREVENTION; COLONY;
D O I
10.1016/j.vetimm.2010.03.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A modification of a highly practical human interferon-gamma release assay for the diagnosis of tuberculosis (TB), the QuantiFERON(R)-TB Gold (In-Tube Method) (QFG-IT) assay, was evaluated for diagnosing natural mycobacterial infection in rhesus macaques (Macaca mulatto). All animals in a captive colony were tested using the QFG-IT and tuberculin skin test (TST). Animals testing positive to these tests were euthanised and necropsied. Selected tissues were processed for histopathology and mycobacterial culture, and positive cultures were speciated by Mycobacterium tuberculosis complex polymerase chain reaction (PCR) and 16S rRNA gene PCR sequencing techniques. M. tuberculosis was cultured from a TST-positive/QFG-IT-positive animal which showed gross pulmonary pathology typical of TB. Additionally, Mycobacterium kansasii was cultured from a TST-negative/QFG-IT-positive animal which had no pathological or histopathological signs of mycobacterial infection. The detection of M. kansasii infection in a QFG-IT-positive animal which showed no evidence of disease indicates that this test might be a highly sensitive tool for the diagnosis of mycobacterial infection in rhesus macaques. However, these findings highlight the limitations of the QFG-IT to specifically detect infection by the pathogens M. tuberculosis and Mycobacterium bovis. (C) 2010 Elsevier BM. All rights reserved.
引用
收藏
页码:330 / 334
页数:5
相关论文
共 46 条
  • [31] A combination of the QuantiFERON-TB Gold In-Tube assay and the detection of adenosine deaminase improves the diagnosis of tuberculous pleural effusion
    Liu, Yuanyuan
    Ou, Qinfang
    Zheng, Jian
    Shen, Lei
    Zhang, Bingyan
    Weng, Xinhua
    Shao, Lingyun
    Gao, Yan
    Zhang, Wenhong
    EMERGING MICROBES & INFECTIONS, 2016, 5
  • [32] Detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer) using QuantiFERON®-TB Gold (QFT) tubes and the Qiagen cattletype® IFN-gamma ELISA
    Bernitz, Netanya
    Clarke, Charlene
    Roos, Eduard O.
    Goosen, Wynand J.
    Cooper, David
    van Helden, Paul D.
    Parsons, Sven D. C.
    Miller, Michele A.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2018, 196 : 48 - 52
  • [33] Evaluation of the QuantiFERON®-TB Gold In-Tube assay and tuberculin skin test for the diagnosis of Mycobacterium tuberculosis infection in northeastern Thailand
    Reechaipichitkul, Wipa
    Pimrin, Wilailuk
    Bourpoern, Janpen
    Prompinij, Supapim
    Faksri, Kiatichai
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2015, 33 (03) : 236 - 244
  • [34] QuantiFERON-TB Gold and selected region of difference 1 peptide-based assays for the detection of Mycobacterium tuberculosis infection in a cohort of patients enrolled with suspected tuberculosis
    Sauzullo, Ilaria
    Mengoni, Fabio
    Lichtner, Mirialn
    Rossi, Raffaella
    Massetti, Anna P.
    Mastroianni, Claudio M.
    Vullo, Vincenzo
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 62 (04) : 395 - 401
  • [35] Comparison of the QuantiFERON-TB® Gold Plus on LIAISON® XL and T-SPOT.TB for the diagnosis of latent Mycobacterium tuberculosis infection in a low tuberculosis incidence population
    Heireman, Laura
    Bruynseels, Peggy
    Camps, Kim
    Geysels, Dieter
    Huyghe, Evelyne
    Andre, Emmanuel
    Van Gasse, Natasja
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2022, 102 (03)
  • [36] QuantiFERON-TB Gold In-Tube Assay for Screening Arthritis Patients for Latent Tuberculosis Infection before Starting Anti-Tumor Necrosis Factor Treatment
    Lee, Hyun
    Park, Hye Yun
    Jeon, Kyeongman
    Jeong, Byeong-Ho
    Hwang, Ji-Won
    Lee, Jaejoon
    Cha, Hoon-Suk
    Koh, Eun-Mi
    Kang, Eun-Suk
    Koh, Won-Jung
    PLOS ONE, 2015, 10 (03):
  • [37] Influential Factors of the Indeterminate Results Tested by QuantiFERON-TB Gold In-Tube (QFT-IT) Assay for Diagnosing TB Infection in HIV-Infected Patients
    Dai, Qinghai
    Qiao, Kunyan
    Zhang, Shitian
    Huo, Zhixiao
    Wang, Jingyu
    Qi, Chunxiao
    Du, Yanan
    Lu, Wei
    Hou, Wei
    CLINICAL LABORATORY, 2016, 62 (09) : 1761 - 1766
  • [38] Parallel measurement of IFN-γ and IP-10 in QuantiFERON®-TB Gold (QFT) plasma improves the detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
    Bernitz, Netanya
    Kerr, Tanya J.
    Goosen, Wynand J.
    Clarke, Charlene
    Higgitt, Roxanne
    Roos, Eduard O.
    Cooper, David V.
    Warren, Robin M.
    van Helden, Paul D.
    Parsons, Sven D. C.
    Miller, Michele A.
    PREVENTIVE VETERINARY MEDICINE, 2019, 169
  • [39] Comparison of QuantiFERON-TB Gold In-Tube Test and Tuberculin Skin Test for Identification of Latent Mycobacterium tuberculosis Infection in Healthcare Staff and Association Between Positive Test Results and Known Risk Factors for Infection
    Vinton, Paul
    Mihrshahi, Seema
    Johnson, Paul
    Jenkin, Grant A.
    Jolley, Damien
    Biggs, Beverley-Ann
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (03) : 215 - 221
  • [40] Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test
    Legesse, Mengistu
    Ameni, Gobena
    Mamo, Gezahegne
    Medhin, Girmay
    Bjune, Gunnar
    Abebe, Fekadu
    BMC INFECTIOUS DISEASES, 2011, 11